Litcius/Paper detail

Adjuvant Olaparib for Patients with BRCA1- or BRCA2-Mutated Breast Cancer

Lynda Wyld, Ramsey Cutress, Jenna Morgan

2024120 citationsDOI

Topics & Concepts

OlaparibMedicineOncologyBreast cancerAdjuvantInternal medicineCancer researchCancerBiologyPoly ADP ribose polymeraseGeneticsGenePolymerasePARP inhibition in cancer therapyBRCA gene mutations in cancerAdvanced Breast Cancer Therapies
Adjuvant Olaparib for Patients with BRCA1- or BRCA2-Mutated Breast Cancer | Litcius